Short communication:: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004

被引：17

作者：

Vega, Juan Carlos

Sanchez, Boris Fernando

Montero, Luz Mery

Montana, Rafael

Mahecha, Mercedes del Pilar

Duenes, Bladimir

Baron, Angela Rocio

Reithinger, Richard

机构：

[1] Univ Militar Nueva Granada, Bogota, Colombia

[2] Univ Bosque, Bogota, Colombia

[3] Hosp San Juan Bautista, Tolima, Colombia

[4] WESTAT Corp, Rockville, MD USA

[5] London Sch Hyg & Trop Med, London, England

[6] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2007年 / 12卷 / 12期

关键词：

leishmaniasis; cost-effectiveness analysis; treatment; prevention and control;

D O I：

10.1111/j.1365-3156.2007.01962.x

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We calculated ranges for the cost per disability adjusted life year (DALY) averted for cutaneous leishmaniasis (CL) treatment during an ongoing epidemic of CL in Chaparral, Colombia. Using operational clinical and cost data, we calculated that the cost of treating leishmaniasis patients with standard pentavalent antimony was US$345 (95% CI 277-488) per patient treated and cured. The cost per DALY averted per patient cured with antimony was estimated to be approximately US$15 000 (95% CI 12 226-21 532).

引用

页码：1540 / 1544

页数：5

共 14 条

[1] Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala [J].